MEC Plus

Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC
Adjuvant and NeoAdjuvant Novel Concepts and Strategies in NSCLC
Karen Kelly, MD
Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?
Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?
Paul A. Bunn, MD, FASCO
Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy
Sequencing Therapy in Early Stage TNBC: Reducing and Increasing the Intensity of Therapy
Mark Pegram, MD
Endocrine Therapy for Early-Stage Breast Cancer: Who Needs more?
Endocrine Therapy for Early-Stage Breast Cancer: Who Needs more?
Mohammad Jahanzeb, MD, FACP, FASCO
Immunotherapy for Triple Negative Breast Cancer
Immunotherapy for Triple Negative Breast Cancer
Windy Dean-Colomb, MD, PhD
New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer
New Agents and New Applications of Targeted Therapy for Hormone Receptor Positive Breast Cancer
Joyce O’Shaughnessy, MD
Antibody Drug Conjugated for Breast Cancer: Current Therapy and New Directions
Antibody Drug Conjugated for Breast Cancer: Current Therapy and New Directions
Hope Rugo, MD, FASCO
Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels
Equity in Cancer Care: Efforts Tackling Barriers at the Government and Legislation Levels
Sybil Richard Green, JD, MHA, BS Pharm
Initiatives to Improve Equity and Inclusion in Healthcare
Initiatives to Improve Equity and Inclusion in Healthcare
Kashyap Patel, MD, ABOIM
Eliminate the Barriers for Disparity in Cancer Care in the 21st Century
Eliminate the Barriers for Disparity in Cancer Care in the 21st Century
Chanita Hughes-Halbert, PhD
Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?
Immunotherapy in Non-Melanoma Skin Cancers (BCC, Squamous & Merkel) and What After IO Failure?
Belisario Arango, MD